UB Paderborn / Katalog / Suche / in CDI

Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 status

European journal of cancer (1990), 2021-09, Vol.155, p.1-12

2021

Volltextzugriff (PDF)

Mutations in BRCA1/2 and Other Panel Genes in Patients With Metastatic Breast Cancer -Association With Patient and Disease Characteristics and Effect on Prognosis

Journal of clinical oncology, 2021-05, Vol.39 (15), p.1619-1630

2021

Volltextzugriff (PDF)

I-PREGNO - prevention of unhealthy weight gain and psychosocial stress in families during pregnancy and postpartum using an mHealth enhanced intervention: a study protocol of two cluster randomized controlled trials

BMC pregnancy and childbirth, 2023-06, Vol.23 (1), p.418-418, Article 418

2023

Volltextzugriff (PDF)

Heregulin (HRG) assessment for clinical trial eligibility testing in a molecular registry (PRAEGNANT) in Germany

BMC cancer, 2020-11, Vol.20 (1), p.1091-1091, Article 1091

2020

Volltextzugriff (PDF)

Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial

The Lancet (British edition), 2017-10, Vol.390 (10104), p.1747-1757

2017

Volltextzugriff (PDF)

Neurochemical Differences in Spinocerebellar Ataxia Type 14 and 1

Cerebellum (London, England), 2021-04, Vol.20 (2), p.169-178

2021

Volltextzugriff (PDF)

Computerized patient identification for the EMBRACA clinical trial using real-time data from the PRAEGNANT network for metastatic breast cancer patients

Breast cancer research and treatment, 2016-07, Vol.158 (1), p.59-65

2016

Volltextzugriff (PDF)

Spinocerebellar ataxia type 14: refining clinicogenetic diagnosis in a rare adult‐onset disorder

Annals of clinical and translational neurology, 2021-04, Vol.8 (4), p.774-789

2021

Volltextzugriff (PDF)

Implementation of a Systematic Literature Search Strategy in a National Breast Cancer Guideline: The Relevance of Systemic Therapy in Lymph Node Recurrent Disease

Oncology research and treatment, 2018-01, Vol.41 (9), p.554-559

2018

Volltextzugriff (PDF)

Use of complementary and integrative medicine among German breast cancer patients: predictors and implications for patient care within the PRAEGNANT study network

Archives of gynecology and obstetrics, 2017-05, Vol.295 (5), p.1239-1245

2017

Volltextzugriff (PDF)

Preexisting musculoskeletal burden and its development under letrozole treatment in early breast cancer patients

International journal of cancer, 2019-10, Vol.145 (8), p.2114-2121

2019

Volltextzugriff (PDF)

Cerebellar neurochemical alterations in spinocerebellar ataxia type 14 appear to include glutathione deficiency

Journal of neurology, 2015-08, Vol.262 (8), p.1927-1935

2015

Volltextzugriff (PDF)

A phase III, open label, randomized multicenter controlled trial of oral versus intravenous treosulfan in heavily pretreated recurrent ovarian cancer: a study of the North-Eastern German Society of Gynecological Oncology (NOGGO)

Journal of cancer research and clinical oncology, 2017-03, Vol.143 (3), p.541-550

2017

Volltextzugriff (PDF)

Financing of certified centers: a willingness-to-pay analysis

Archives of gynecology and obstetrics, 2013-03, Vol.287 (3), p.495-509

2013

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 status

Mutations in BRCA1/2 and Other Panel Genes in Patients With Metastatic Breast Cancer -Association With Patient and Disease Characteristics and Effect on Prognosis

I-PREGNO - prevention of unhealthy weight gain and psychosocial stress in families during pregnancy and postpartum using an mHealth enhanced intervention: a study protocol of two cluster randomized controlled trials

Heregulin (HRG) assessment for clinical trial eligibility testing in a molecular registry (PRAEGNANT) in Germany

Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial

Neurochemical Differences in Spinocerebellar Ataxia Type 14 and 1

Treatment landscape of advanced breast cancer patients with hormone receptor positive HER2 negative tumors – Data from the German PRAEGNANT breast cancer registry

Computerized patient identification for the EMBRACA clinical trial using real-time data from the PRAEGNANT network for metastatic breast cancer patients

Spinocerebellar ataxia type 14: refining clinicogenetic diagnosis in a rare adult‐onset disorder

Implementation of a Systematic Literature Search Strategy in a National Breast Cancer Guideline: The Relevance of Systemic Therapy in Lymph Node Recurrent Disease

Use of complementary and integrative medicine among German breast cancer patients: predictors and implications for patient care within the PRAEGNANT study network

Preexisting musculoskeletal burden and its development under letrozole treatment in early breast cancer patients

Cerebellar neurochemical alterations in spinocerebellar ataxia type 14 appear to include glutathione deficiency

A phase III, open label, randomized multicenter controlled trial of oral versus intravenous treosulfan in heavily pretreated recurrent ovarian cancer: a study of the North-Eastern German Society of Gynecological Oncology (NOGGO)

Financing of certified centers: a willingness-to-pay analysis

Aktive Filter

Suchergebnisse filtern